E2F4 regulatory program predicts patient survival prognosis in breast cancer

INTRODUCTION: Genetic and molecular signatures have been incorporated into cancer prognosis prediction and treatment decisions with good success over the past decade. Clinically, these signatures are usually used in early-stage cancers to evaluate whether they require adjuvant therapy following surg...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaleel, Sari S, Andrews, Erik H, Ung, Matthew, DiRenzo, James, Cheng, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303196/
https://www.ncbi.nlm.nih.gov/pubmed/25440089
http://dx.doi.org/10.1186/s13058-014-0486-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303196/
https://www.ncbi.nlm.nih.gov/pubmed/25440089
http://dx.doi.org/10.1186/s13058-014-0486-7

Ejemplares similares